The Mumbai-based firm had on Friday received the manufacturing and marketing approval from the Drugs Controller General of India (DCGI).

“This approval comes at a time when cases in India are spiralling like never before, putting a tremendous pressure on our healthcare system,” Glenmark Pharmaceuticals Chairman and MD Glenn Saldanha said in the statement.

Ireland became the latest country to warn its citizens that medical assistance may become difficult with India’s sharp spike in cases and urged them to consider making use of a series of evacuation flights in the next few weeks.In an email seen by Reuters, the embassy’s second secretary, Máirtín Cronin, warned Irish citizens that access to medical care for COVID-19 and non-COVID-19 treatment may become increasingly difficult in the coming period.

In some positive news, the number of recoveries  crossed the two lakh mark and stands at 2,04,710, while there are 1,63,248 total COVID-19 active cases, according to the updated official figure at 8 am. One patient had migrated.

“Thus, around 53.79 per cent patients have recovered so far,” an official said.